Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/32145
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cliff, Edward R Scheffer | - |
dc.contributor.author | Reynolds, Gemma | - |
dc.contributor.author | Grigg, Andrew P | - |
dc.date | 2023 | - |
dc.date.accessioned | 2023-02-14T04:27:40Z | - |
dc.date.available | 2023-02-14T04:27:40Z | - |
dc.date.issued | 2023-02-08 | - |
dc.identifier.citation | Clinical Hematology International 2023 | en_US |
dc.identifier.issn | 2590-0048 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/32145 | - |
dc.description.abstract | Invasive fungal infections (IFI) are challenging to predict, diagnose and treat, and are associated with a particularly high mortality among patients with hematological malignancies. They are relatively uncommon in patients with lymphoma, compared with those with acute leukemia or undergoing allogeneic transplantation. We present a patient, autografted for recurrent lymphoma, with fever and refractory diarrhea persisting post engraftment, eventually attributable to disseminated mucor infection. This case illustrates the challenge of timely diagnosis and initiation of treatment for IFI in lymphoma patients, who do not routinely receive antifungal prophylaxis, and the importance of aggressive investigation and symptom-directed tissue sampling for evidence of IFI in febrile immunocompromised hosts not responding to broad-spectrum antibiotics. | en_US |
dc.language.iso | eng | - |
dc.subject | Autologous stem cell transplant | en_US |
dc.subject | Invasive fungal infection | en_US |
dc.subject | Lymphoma | en_US |
dc.subject | Mucor | en_US |
dc.subject | Mucormycosis | en_US |
dc.title | Disseminated Invasive Mucormycosis Infection Following Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | Clinical Hematology International | en_US |
dc.identifier.affiliation | Clinical Haematology | en_US |
dc.identifier.affiliation | Infectious Diseases | en_US |
dc.identifier.affiliation | Olivia Newton-John Cancer Research Institute | en_US |
dc.identifier.doi | 10.1007/s44228-023-00031-z | en_US |
dc.type.content | Text | en_US |
dc.identifier.pubmedid | 36750525 | - |
dc.description.startpage | 1 | - |
dc.description.endpage | 7 | - |
local.name.researcher | Grigg, Andrew P | |
item.openairetype | Journal Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Olivia Newton-John Cancer Wellness and Research Centre | - |
crisitem.author.dept | Clinical Haematology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.